The stock market performance of Genmab ADR has been fairly unsteady. Over the last year, the company’s stock hit its highest at $31.02 on 03/27/24, while the lowest price during the same time frame was $18.64, recorded on 02/10/25.
52-week price history of GMAB Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Genmab ADR’s current trading price is -36.75% away from its 52-week high, while its distance from the 52-week low is 5.29%. The stock’s price range for this period has remained between $18.64 and $31.02. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.32 million for the day, which was noticeably lower compared to the shares’ average daily volume of 1.48 million over the last three months.
Financial Performance and Market Capitalization
Genmab ADR (GMAB) has experienced a quarterly decline of -3.40% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 12.47B and boasts a workforce of 2682 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 21.17, with a change in price of -3.50. Similarly, Genmab ADR recorded 1,407,131 in trading volume during the last 100 days, posting a change of -15.14%.
GMAB Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for GMAB stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.
GMAB Stock Stochastic Average
As of today, the raw stochastic average of Genmab ADR over the last 50 days is at 17.31%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 11.81%. Further, the company’s Stochastic %K and %D values for the last 20 days were 6.25% and 4.31%, respectively.
GMAB Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a loss of -5.99%.However, over the last six months, we can see a stronger performance of -18.72%. Over the last 30 days, the price of GMAB has leaped by -14.55%. And in the last five days, it has fallen by -3.11%.
